Chemours (NYSE:CC) reported quarterly earnings of $0.42 per share which met the analyst consensus estimate. This is a 27.59 percent decrease over earnings of $0.58 per share from the same period last year. The company reported quarterly sales of $1.591 billion which missed the analyst consensus estimate of $1.654 billion by 3.81 percent. This is a 1.49 percent decrease over sales of $1.615 billion the same period last year.